Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease

OBJECTIVE: To test the safety, tolerability, and pharmacokinetics of the anti- TNF-α monoclonal antibody, infliximab, in subjects with intravenous immunoglobulin (IVIG)-resistant Kawasaki disease (KD). STUDY DESIGN: We conducted a multicenter, randomized, prospective trial of second IVIG infusion (2...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Burns, Jane C., Best, Brookie M., Mejias, Asuncion, Mahony, Lynn, Fixler, David E., Jafri, Hasan S., Melish, Marian E., Jackson, Mary Anne, Asmar, Basim I., Lang, David J., Connor, James D., Capparelli, Edmund V., Keen, Monica L., Mamun, Khalid, Keenan, Gregory F., Ramilo, Octavio
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2008
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2856847/
https://ncbi.nlm.nih.gov/pubmed/18672254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpeds.2008.06.011
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg